Furthermore, even the non-canonical degradation and MHC1 processing of the ovarian cancer antigen NY-ESO-1 was only mildly impacted by knockdown of RPN13, but potently blocked by immunoproteasome inhibitors [62]. The gene discussed is ADRM1; the disease is cancer.